| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.26e-14 | 46 | 61 | 9 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 5.46e-09 | 188 | 61 | 9 | GO:0005201 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.83e-08 | 12 | 61 | 4 | GO:0048407 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL3A1 COL4A2 MAGI2 COL4A6 COL5A2 COL7A1 COL27A1 BSN COL1A1 COL1A2 | 7.09e-05 | 891 | 61 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 1.14e-04 | 156 | 61 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.39e-04 | 86 | 61 | 4 | GO:0046332 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 7.12e-08 | 76 | 58 | 6 | GO:0030199 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 ZNF469 COL27A1 COL1A1 COL1A2 | 8.83e-08 | 377 | 58 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 ZNF469 COL27A1 COL1A1 COL1A2 | 9.05e-08 | 378 | 58 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 ZNF469 COL27A1 COL1A1 COL1A2 | 9.28e-08 | 379 | 58 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 4.56e-06 | 12 | 58 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 1.67e-05 | 18 | 58 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 7.23e-05 | 79 | 58 | 4 | GO:0060350 | |
| GeneOntologyBiologicalProcess | cellular response to amino acid stimulus | 8.93e-05 | 161 | 58 | 5 | GO:0071230 | |
| GeneOntologyBiologicalProcess | cellular response to acid chemical | 1.39e-04 | 177 | 58 | 5 | GO:0071229 | |
| GeneOntologyBiologicalProcess | anterior head development | 2.15e-04 | 8 | 58 | 2 | GO:0097065 | |
| GeneOntologyBiologicalProcess | response to amino acid | 2.58e-04 | 202 | 58 | 5 | GO:0043200 | |
| GeneOntologyBiologicalProcess | skeletal system development | 3.07e-04 | 615 | 58 | 8 | GO:0001501 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 3.13e-04 | 47 | 58 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 4.11e-04 | 124 | 58 | 4 | GO:0060349 | |
| GeneOntologyBiologicalProcess | response to acid chemical | 4.49e-04 | 228 | 58 | 5 | GO:0001101 | |
| GeneOntologyCellularComponent | complex of collagen trimers | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 2.02e-18 | 21 | 60 | 9 | GO:0098644 |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 6.55e-14 | 88 | 60 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 3.94e-13 | 12 | 60 | 6 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 3.94e-13 | 12 | 60 | 6 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 HNRNPM COL1A1 COL1A2 | 2.80e-07 | 530 | 60 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 4.19e-07 | 332 | 60 | 9 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 HNRNPM COL1A1 COL1A2 | 2.26e-06 | 656 | 60 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 HNRNPM COL1A1 COL1A2 | 2.33e-06 | 658 | 60 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type I trimer | 8.10e-06 | 2 | 60 | 2 | GO:0005584 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 8.06e-05 | 5 | 60 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.21e-04 | 6 | 60 | 2 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 2.24e-04 | 8 | 60 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.24e-04 | 8 | 60 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.24e-04 | 8 | 60 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 4.18e-04 | 122 | 60 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 KIF26A COL27A1 RP1L1 APC2 COL1A1 COL1A2 | 4.96e-04 | 1187 | 60 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | synaptic membrane | 1.36e-03 | 583 | 60 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | postsynaptic density | 1.83e-03 | 451 | 60 | 6 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.42e-03 | 477 | 60 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.14e-03 | 503 | 60 | 6 | GO:0099572 | |
| GeneOntologyCellularComponent | inhibitory synapse | 3.57e-03 | 31 | 60 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 3.80e-03 | 523 | 60 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | extrinsic component of membrane | 4.30e-03 | 230 | 60 | 4 | GO:0019898 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.08e-03 | 405 | 60 | 5 | GO:0045211 | |
| GeneOntologyCellularComponent | supramolecular fiber | COL2A1 COL3A1 COL5A2 KIF26A COL27A1 RP1L1 APC2 COL1A1 COL1A2 | 6.17e-03 | 1179 | 60 | 9 | GO:0099512 |
| HumanPheno | Molluscoid pseudotumors | 9.06e-09 | 7 | 22 | 4 | HP:0000993 | |
| HumanPheno | Arterial rupture | 1.81e-08 | 8 | 22 | 4 | HP:0025019 | |
| HumanPheno | Soft, doughy skin | 2.54e-07 | 14 | 22 | 4 | HP:0001027 | |
| HumanPheno | Cervical insufficiency | 2.79e-07 | 4 | 22 | 3 | HP:0030009 | |
| HumanPheno | Atrophic scars | 3.68e-07 | 37 | 22 | 5 | HP:0001075 | |
| HumanPheno | Fragile skin | 3.68e-07 | 37 | 22 | 5 | HP:0001030 | |
| HumanPheno | Atypical scarring of skin | 4.75e-07 | 74 | 22 | 6 | HP:0000987 | |
| HumanPheno | Mitral valve prolapse | 5.09e-07 | 123 | 22 | 7 | HP:0001634 | |
| HumanPheno | Soft skin | 8.99e-07 | 44 | 22 | 5 | HP:0000977 | |
| HumanPheno | Abnormal hip joint morphology | COL2A1 COL3A1 XYLT1 COL5A2 ZNF469 COL27A1 APC2 SLC35A2 TET3 COL1A1 COL1A2 | 1.54e-06 | 490 | 22 | 11 | HP:0001384 |
| HumanPheno | Abnormal mitral valve morphology | 1.64e-06 | 146 | 22 | 7 | HP:0031477 | |
| HumanPheno | Abnormal synovial membrane morphology | COL2A1 COL3A1 XYLT1 COL5A2 ZNF469 COL27A1 APC2 SLC35A2 TET3 COL1A1 COL1A2 | 2.01e-06 | 503 | 22 | 11 | HP:0005262 |
| HumanPheno | Uterine prolapse | 2.42e-06 | 7 | 22 | 3 | HP:0000139 | |
| HumanPheno | Scarring | 3.20e-06 | 102 | 22 | 6 | HP:0100699 | |
| HumanPheno | Genital hernia | 3.86e-06 | 8 | 22 | 3 | HP:0100823 | |
| HumanPheno | Joint subluxation | 7.61e-06 | 31 | 22 | 4 | HP:0032153 | |
| HumanPheno | Hip dislocation | 7.71e-06 | 263 | 22 | 8 | HP:0002827 | |
| HumanPheno | Coxa vara | 8.07e-06 | 68 | 22 | 5 | HP:0002812 | |
| HumanPheno | Cigarette-paper scars | 8.23e-06 | 10 | 22 | 3 | HP:0001073 | |
| HumanPheno | Flexion contracture of digit | 9.08e-06 | 362 | 22 | 9 | HP:0030044 | |
| HumanPheno | Pes planus | 9.72e-06 | 365 | 22 | 9 | HP:0001763 | |
| HumanPheno | Bell-shaped thorax | 9.84e-06 | 33 | 22 | 4 | HP:0001591 | |
| HumanPheno | Abnormality of lower limb joint | COL2A1 COL3A1 ALX3 XYLT1 COL5A2 COL7A1 ZNF469 COL27A1 APC2 SLC35A2 WDR73 TET3 COL1A1 COL1A2 | 1.06e-05 | 1027 | 22 | 14 | HP:0100491 |
| HumanPheno | Bladder diverticulum | 1.40e-05 | 36 | 22 | 4 | HP:0000015 | |
| HumanPheno | Arterial dissection | 1.50e-05 | 12 | 22 | 3 | HP:0005294 | |
| HumanPheno | Arteriovenous fistula | 1.50e-05 | 12 | 22 | 3 | HP:0004947 | |
| HumanPheno | Biconcave flattened vertebrae | 1.78e-05 | 2 | 22 | 2 | HP:0003321 | |
| HumanPheno | Absent ossification of calvaria | 1.78e-05 | 2 | 22 | 2 | HP:0005623 | |
| HumanPheno | Severe generalized osteoporosis | 1.78e-05 | 2 | 22 | 2 | HP:0005897 | |
| HumanPheno | Femoral bowing present at birth, straightening with time | 1.78e-05 | 2 | 22 | 2 | HP:0005005 | |
| HumanPheno | Abnormal uterine cervix morphology | 1.95e-05 | 13 | 22 | 3 | HP:0012888 | |
| HumanPheno | Recurrent joint dislocation | 2.47e-05 | 14 | 22 | 3 | HP:0031869 | |
| HumanPheno | Neonatal short-limb short stature | 2.47e-05 | 14 | 22 | 3 | HP:0008921 | |
| HumanPheno | Abnormal hip bone morphology | COL2A1 COL3A1 XYLT1 COL5A2 ZNF469 COL27A1 APC2 SLC35A2 TET3 COL1A1 COL1A2 | 2.61e-05 | 653 | 22 | 11 | HP:0003272 |
| HumanPheno | Lower extremity joint dislocation | 3.12e-05 | 318 | 22 | 8 | HP:0030311 | |
| HumanPheno | Coxa valga | 3.56e-05 | 92 | 22 | 5 | HP:0002673 | |
| HumanPheno | Joint hypermobility | COL2A1 COL3A1 XYLT1 COL5A2 ZNF469 APC2 SLC35A2 TET3 COL1A1 COL1A2 | 4.30e-05 | 557 | 22 | 10 | HP:0001382 |
| HumanPheno | Abnormal femoral neck morphology | 4.30e-05 | 160 | 22 | 6 | HP:0003367 | |
| HumanPheno | Upper extremity joint dislocation | 4.37e-05 | 96 | 22 | 5 | HP:0030310 | |
| HumanPheno | Premature rupture of membranes | 4.57e-05 | 17 | 22 | 3 | HP:0001788 | |
| HumanPheno | Hyperextensible skin | 4.61e-05 | 162 | 22 | 6 | HP:0000974 | |
| HumanPheno | Hip dysplasia | 5.28e-05 | 247 | 22 | 7 | HP:0001385 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 5.33e-05 | 3 | 22 | 2 | HP:0006201 | |
| HumanPheno | Pulmonary bleb | 5.33e-05 | 3 | 22 | 2 | HP:0032447 | |
| HumanPheno | Popcorn calcification | 5.33e-05 | 3 | 22 | 2 | HP:6000871 | |
| HumanPheno | Subcutaneous spheroids | 5.33e-05 | 3 | 22 | 2 | HP:0025014 | |
| HumanPheno | Abnormal joint physiology | COL2A1 COL3A1 ALX3 XYLT1 COL5A2 COL7A1 ZNF469 KIF26A COL27A1 APC2 SLC35A2 WDR73 TET3 COL1A1 COL1A2 | 5.40e-05 | 1358 | 22 | 15 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL2A1 COL3A1 ALX3 XYLT1 COL5A2 COL7A1 ZNF469 KIF26A COL27A1 APC2 SLC35A2 WDR73 TET3 COL1A1 COL1A2 | 5.40e-05 | 1358 | 22 | 15 | HP:0011729 |
| HumanPheno | Abnormality of upper limb joint | COL2A1 ALX3 XYLT1 COL5A2 COL7A1 COL27A1 APC2 SLC35A2 WDR73 COL1A1 COL1A2 | 5.44e-05 | 705 | 22 | 11 | HP:0009810 |
| HumanPheno | Camptodactyly | 5.75e-05 | 346 | 22 | 8 | HP:0012385 | |
| HumanPheno | Short limb dwarfism | 6.48e-05 | 19 | 22 | 3 | HP:0003505 | |
| HumanPheno | Flexion contracture of finger | 6.80e-05 | 257 | 22 | 7 | HP:0012785 | |
| HumanPheno | Abnormal mitral valve morphology | 6.80e-05 | 257 | 22 | 7 | HP:0001633 | |
| HumanPheno | Abnormality of the dentition | COL2A1 COL3A1 ALX3 XYLT1 COL5A2 COL7A1 ZNF469 APC2 SLC35A2 WDR73 PLXNA1 COL1A1 COL1A2 | 7.01e-05 | 1030 | 22 | 13 | HP:0000164 |
| HumanPheno | Finger joint contracture | 7.15e-05 | 259 | 22 | 7 | HP:0034681 | |
| HumanPheno | Dislocated radial head | 7.16e-05 | 54 | 22 | 4 | HP:0003083 | |
| HumanPheno | Abnormal tendon morphology | COL2A1 COL3A1 ALX3 XYLT1 COL7A1 ZNF469 KIF26A APC2 SLC35A2 WDR73 COL1A1 COL1A2 | 7.34e-05 | 875 | 22 | 12 | HP:0100261 |
| HumanPheno | Dermal atrophy | 7.38e-05 | 107 | 22 | 5 | HP:0004334 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | COL2A1 COL3A1 XYLT1 COL5A2 ZNF469 COL27A1 APC2 SLC35A2 TET3 COL1A1 COL1A2 | 7.57e-05 | 730 | 22 | 11 | HP:0002644 |
| HumanPheno | Shoulder dislocation | 7.60e-05 | 20 | 22 | 3 | HP:0003834 | |
| HumanPheno | Generalized osteoporosis | 7.60e-05 | 20 | 22 | 3 | HP:0040160 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 7.70e-05 | 262 | 22 | 7 | HP:0006261 | |
| HumanPheno | Blue sclerae | 7.71e-05 | 108 | 22 | 5 | HP:0000592 | |
| HumanPheno | Abnormally lax or hyperextensible skin | 8.08e-05 | 179 | 22 | 6 | HP:0008067 | |
| HumanPheno | Dwarfism | 8.84e-05 | 21 | 22 | 3 | HP:0001516 | |
| HumanPheno | Abnormality of the radial head | 8.87e-05 | 57 | 22 | 4 | HP:0003995 | |
| HumanPheno | Abnormality of dental structure | 8.93e-05 | 368 | 22 | 8 | HP:0011061 | |
| HumanPheno | Pretibial blistering | 1.06e-04 | 4 | 22 | 2 | HP:0012221 | |
| HumanPheno | Piezogenic pedal papules | 1.06e-04 | 4 | 22 | 2 | HP:0025509 | |
| HumanPheno | Bowing of limbs due to multiple fractures | 1.06e-04 | 4 | 22 | 2 | HP:0003023 | |
| HumanPheno | Incisional hernia | 1.06e-04 | 4 | 22 | 2 | HP:0004872 | |
| HumanPheno | Dentinogenesis imperfecta | 1.17e-04 | 23 | 22 | 3 | HP:0000703 | |
| HumanPheno | Abnormality of the humeroradial joint | 1.24e-04 | 62 | 22 | 4 | HP:0100744 | |
| HumanPheno | Joint dislocation | 1.35e-04 | 390 | 22 | 8 | HP:0001373 | |
| HumanPheno | Osteoarthritis | 1.49e-04 | 65 | 22 | 4 | HP:0002758 | |
| HumanPheno | Biconcave vertebral bodies | 1.51e-04 | 25 | 22 | 3 | HP:0004586 | |
| HumanPheno | Abnormal femoral neck/head morphology | 1.54e-04 | 201 | 22 | 6 | HP:0003366 | |
| HumanPheno | Talipes equinovarus | 1.58e-04 | 399 | 22 | 8 | HP:0001762 | |
| HumanPheno | Joint contracture of the hand | 1.67e-04 | 296 | 22 | 7 | HP:0009473 | |
| HumanPheno | Lower-limb joint contracture | 1.70e-04 | 403 | 22 | 8 | HP:0005750 | |
| HumanPheno | Abnormal dentin morphology | 1.71e-04 | 26 | 22 | 3 | HP:0010299 | |
| HumanPheno | Hypermobility of interphalangeal joints | 1.77e-04 | 5 | 22 | 2 | HP:0005620 | |
| HumanPheno | Basilar impression | 1.77e-04 | 5 | 22 | 2 | HP:0005758 | |
| HumanPheno | Papule | 1.91e-04 | 209 | 22 | 6 | HP:0200034 | |
| HumanPheno | Dermal translucency | 1.91e-04 | 27 | 22 | 3 | HP:0010648 | |
| HumanPheno | Aortic root aneurysm | 1.98e-04 | 70 | 22 | 4 | HP:0002616 | |
| HumanPheno | Flexion contracture | COL2A1 COL3A1 ALX3 XYLT1 COL7A1 ZNF469 KIF26A APC2 SLC35A2 WDR73 COL1A1 | 2.16e-04 | 817 | 22 | 11 | HP:0001371 |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 2.63e-04 | 30 | 22 | 3 | HP:0005743 | |
| HumanPheno | Crumpled long bones | 2.64e-04 | 6 | 22 | 2 | HP:0006367 | |
| HumanPheno | Abnormal sclera morphology | 2.73e-04 | 141 | 22 | 5 | HP:0000591 | |
| HumanPheno | Joint contracture | COL2A1 COL3A1 ALX3 XYLT1 COL7A1 ZNF469 KIF26A APC2 SLC35A2 WDR73 COL1A1 | 2.88e-04 | 843 | 22 | 11 | HP:0034392 |
| HumanPheno | Foot joint contracture | 3.53e-04 | 334 | 22 | 7 | HP:0008366 | |
| HumanPheno | Abnormal finger morphology | COL2A1 COL3A1 ALX3 XYLT1 COL5A2 COL7A1 ZNF469 KLF13 COL27A1 APC2 SLC35A2 WDR73 COL1A1 COL1A2 | 3.66e-04 | 1385 | 22 | 14 | HP:0001167 |
| HumanPheno | Pulp calcification | 3.69e-04 | 7 | 22 | 2 | HP:0003771 | |
| HumanPheno | Otosclerosis | 3.69e-04 | 7 | 22 | 2 | HP:0000362 | |
| HumanPheno | Phalangeal dislocation | 3.69e-04 | 7 | 22 | 2 | HP:0006243 | |
| HumanPheno | Abnormal elasticity of skin | 3.87e-04 | 238 | 22 | 6 | HP:0010647 | |
| HumanPheno | Abnormal forearm morphology | 3.96e-04 | 239 | 22 | 6 | HP:0002973 | |
| HumanPheno | Dilatation of the ascending aorta | 4.01e-04 | 84 | 22 | 4 | HP:0005111 | |
| HumanPheno | Elbow dislocation | 4.01e-04 | 84 | 22 | 4 | HP:0003042 | |
| MousePheno | abnormal dermal layer morphology | 2.67e-05 | 108 | 46 | 5 | MP:0001243 | |
| MousePheno | abnormal synovial joint morphology | 5.19e-05 | 124 | 46 | 5 | MP:0030804 | |
| MousePheno | decreased bone trabecula number | 8.03e-05 | 70 | 46 | 4 | MP:0010869 | |
| MousePheno | abnormal cutaneous collagen fibril morphology | 9.23e-05 | 27 | 46 | 3 | MP:0008438 | |
| MousePheno | abnormal compact bone lamellar structure | 1.05e-04 | 5 | 46 | 2 | MP:0010970 | |
| MousePheno | decreased tendon stiffness | 1.05e-04 | 5 | 46 | 2 | MP:0003098 | |
| MousePheno | abnormal tendon physiology | 1.58e-04 | 6 | 46 | 2 | MP:0030802 | |
| MousePheno | abnormal tendon stiffness | 1.58e-04 | 6 | 46 | 2 | MP:0003097 | |
| MousePheno | retrognathia | 2.20e-04 | 7 | 46 | 2 | MP:0004282 | |
| Domain | Collagen | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 9.65e-14 | 85 | 58 | 10 | PF01391 |
| Domain | Collagen | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 9.65e-14 | 85 | 58 | 10 | IPR008160 |
| Domain | NC1_FIB | 3.14e-13 | 11 | 58 | 6 | PS51461 | |
| Domain | Fib_collagen_C | 3.14e-13 | 11 | 58 | 6 | IPR000885 | |
| Domain | Fib_collagen_C | 3.14e-13 | 11 | 58 | 6 | PD002078 | |
| Domain | COLFI | 3.14e-13 | 11 | 58 | 6 | SM00038 | |
| Domain | COLFI | 3.14e-13 | 11 | 58 | 6 | PF01410 | |
| Domain | VWC | 1.62e-06 | 28 | 58 | 4 | PF00093 | |
| Domain | VWFC_1 | 4.58e-06 | 36 | 58 | 4 | PS01208 | |
| Domain | VWC | 5.71e-06 | 38 | 58 | 4 | SM00214 | |
| Domain | VWFC_2 | 5.71e-06 | 38 | 58 | 4 | PS50184 | |
| Domain | VWF_dom | 8.58e-06 | 42 | 58 | 4 | IPR001007 | |
| Domain | C4 | 1.41e-04 | 6 | 58 | 2 | SM00111 | |
| Domain | - | 1.41e-04 | 6 | 58 | 2 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 1.41e-04 | 6 | 58 | 2 | IPR001442 | |
| Domain | NC1_IV | 1.41e-04 | 6 | 58 | 2 | PS51403 | |
| Domain | C4 | 1.41e-04 | 6 | 58 | 2 | PF01413 | |
| Domain | Sialidases | 3.36e-04 | 9 | 58 | 2 | IPR011040 | |
| Domain | TIG | 4.16e-03 | 31 | 58 | 2 | PF01833 | |
| Domain | IPT | 4.43e-03 | 32 | 58 | 2 | IPR002909 | |
| Domain | CTDL_fold | 4.49e-03 | 107 | 58 | 3 | IPR016187 | |
| Domain | WW | 9.37e-03 | 47 | 58 | 2 | PF00397 | |
| Domain | WW | 9.76e-03 | 48 | 58 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 1.10e-02 | 51 | 58 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.10e-02 | 51 | 58 | 2 | PS01159 | |
| Domain | WW_dom | 1.14e-02 | 52 | 58 | 2 | IPR001202 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 2.99e-15 | 44 | 40 | 9 | M27812 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 7.08e-14 | 61 | 40 | 9 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.72e-13 | 67 | 40 | 9 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.78e-13 | 41 | 40 | 8 | MM15538 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.82e-13 | 50 | 40 | 8 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.61e-12 | 53 | 40 | 8 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.72e-12 | 32 | 40 | 7 | MM14924 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 2.72e-12 | 90 | 40 | 9 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.27e-12 | 61 | 40 | 8 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 7.87e-12 | 64 | 40 | 8 | M26953 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 3.27e-11 | 76 | 40 | 8 | MM14573 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.27e-11 | 76 | 40 | 8 | MM14867 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.20e-11 | 46 | 40 | 7 | M198 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.20e-11 | 85 | 40 | 8 | M16441 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.99e-10 | 30 | 40 | 6 | M27772 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.61e-10 | 59 | 40 | 7 | M27218 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 4.17e-10 | 15 | 40 | 5 | M27161 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.87e-10 | 66 | 40 | 7 | M18 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.85e-10 | 114 | 40 | 8 | MM14571 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.33e-09 | 74 | 40 | 7 | M160 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.47e-09 | 41 | 40 | 6 | M27778 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.60e-09 | 19 | 40 | 5 | M27221 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.60e-09 | 19 | 40 | 5 | MM15512 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.61e-09 | 76 | 40 | 7 | M27219 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.29e-09 | 84 | 40 | 7 | M7098 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.55e-09 | 140 | 40 | 8 | M587 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.92e-08 | 30 | 40 | 5 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.42e-08 | 79 | 40 | 6 | M27643 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.22e-07 | 300 | 40 | 9 | M610 |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.65e-07 | 18 | 40 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.65e-07 | 18 | 40 | 4 | MM14882 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.00e-07 | 47 | 40 | 5 | MM14925 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.61e-07 | 20 | 40 | 4 | MM15061 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.23e-07 | 258 | 40 | 8 | MM14572 | |
| Pathway | WP_FOCAL_ADHESION | 8.32e-07 | 187 | 40 | 7 | MM15913 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 9.30e-07 | 27 | 40 | 4 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 1.08e-06 | 28 | 40 | 4 | MM15957 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.21e-06 | 67 | 40 | 5 | MM15345 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.26e-06 | 199 | 40 | 7 | M7253 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.83e-06 | 38 | 40 | 4 | MM14969 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.75e-06 | 42 | 40 | 4 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.33e-06 | 43 | 40 | 4 | M39565 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 7.95e-06 | 98 | 40 | 5 | M27152 | |
| Pathway | WP_FOCAL_ADHESION | 1.89e-05 | 199 | 40 | 6 | M39402 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.96e-05 | 302 | 40 | 7 | M39719 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.97e-05 | 57 | 40 | 4 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.11e-05 | 58 | 40 | 4 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.93e-05 | 63 | 40 | 4 | M11187 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 3.21e-05 | 326 | 40 | 7 | MM15917 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.15e-05 | 30 | 40 | 3 | MM15812 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.15e-05 | 30 | 40 | 3 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 8.15e-05 | 30 | 40 | 3 | M39641 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.03e-04 | 532 | 40 | 8 | M27870 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 1.30e-04 | 35 | 40 | 3 | MM14512 | |
| Pathway | REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE | 1.30e-04 | 35 | 40 | 3 | M773 | |
| Pathway | REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN | 1.63e-04 | 7 | 40 | 2 | M48265 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 1.89e-04 | 190 | 40 | 5 | M8240 | |
| Pathway | REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 2.17e-04 | 8 | 40 | 2 | M48236 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 2.41e-04 | 43 | 40 | 3 | M53 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.48e-04 | 10 | 40 | 2 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 3.48e-04 | 10 | 40 | 2 | MM1560 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.78e-04 | 50 | 40 | 3 | M48087 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.25e-04 | 11 | 40 | 2 | M15422 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 4.75e-04 | 54 | 40 | 3 | M42568 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 5.09e-04 | 12 | 40 | 2 | MM15093 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.09e-04 | 12 | 40 | 2 | MM1526 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 5.09e-04 | 12 | 40 | 2 | MM15452 | |
| Pathway | REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING | 5.09e-04 | 12 | 40 | 2 | M27352 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 5.63e-04 | 135 | 40 | 4 | MM14781 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.00e-04 | 13 | 40 | 2 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 6.00e-04 | 13 | 40 | 2 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.99e-04 | 14 | 40 | 2 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.99e-04 | 14 | 40 | 2 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.05e-04 | 15 | 40 | 2 | MM14922 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.11e-04 | 261 | 40 | 5 | MM15676 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 8.36e-04 | 725 | 40 | 8 | M27507 | |
| Pathway | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | 9.19e-04 | 16 | 40 | 2 | M9450 | |
| Pathway | WP_UROTENSINIIMEDIATED_SIGNALING | 9.74e-04 | 69 | 40 | 3 | M48052 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.07e-03 | 418 | 40 | 6 | MM15587 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 1.17e-03 | 18 | 40 | 2 | M39421 | |
| Pathway | REACTOME_DISEASES_OF_HEMOSTASIS | 1.30e-03 | 19 | 40 | 2 | M48230 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.44e-03 | 20 | 40 | 2 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.91e-03 | 23 | 40 | 2 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 1.91e-03 | 23 | 40 | 2 | MM1427 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 2.26e-03 | 25 | 40 | 2 | M274 | |
| Pathway | WP_PI3KAKT_SIGNALING | 2.57e-03 | 339 | 40 | 5 | M39736 | |
| Pathway | WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY | 2.83e-03 | 28 | 40 | 2 | M42541 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.92e-03 | 33 | 40 | 2 | M39870 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 5.17e-03 | 38 | 40 | 2 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 5.44e-03 | 39 | 40 | 2 | M10735 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.60e-15 | 62 | 61 | 9 | 28344315 |
| Pubmed | 3.37e-12 | 50 | 61 | 7 | 23658023 | ||
| Pubmed | COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.53e-11 | 167 | 61 | 9 | 22159717 | |
| Pubmed | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 2.33e-11 | 175 | 61 | 9 | 28071719 | |
| Pubmed | 4.28e-11 | 5 | 61 | 4 | 15365990 | ||
| Pubmed | 6.04e-11 | 16 | 61 | 5 | 17881772 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 1.03e-10 | 135 | 61 | 8 | 28675934 | |
| Pubmed | 1.28e-10 | 6 | 61 | 4 | 9101290 | ||
| Pubmed | 1.60e-10 | 19 | 61 | 5 | 15689378 | ||
| Pubmed | 5.96e-10 | 8 | 61 | 4 | 1377218 | ||
| Pubmed | 5.96e-10 | 8 | 61 | 4 | 18816857 | ||
| Pubmed | 7.26e-10 | 25 | 61 | 5 | 19180518 | ||
| Pubmed | 1.07e-09 | 9 | 61 | 4 | 9878537 | ||
| Pubmed | 1.07e-09 | 9 | 61 | 4 | 8900172 | ||
| Pubmed | 1.78e-09 | 10 | 61 | 4 | 14559231 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 23546968 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 34205850 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 5.13e-09 | 3 | 61 | 3 | 8785585 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 5.13e-09 | 3 | 61 | 3 | 1879336 | |
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 12200454 | ||
| Pubmed | 5.13e-09 | 3 | 61 | 3 | 17662583 | ||
| Pubmed | Distributions of types I, II and III collagen by region in the human supraspinatus tendon. | 5.13e-09 | 3 | 61 | 3 | 24088220 | |
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 5.13e-09 | 3 | 61 | 3 | 1297453 | |
| Pubmed | Mutations in collagen genes: causes of rare and some common diseases in humans. | 5.13e-09 | 3 | 61 | 3 | 2010058 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 9.53e-09 | 86 | 61 | 6 | 28327460 | |
| Pubmed | 9.93e-09 | 153 | 61 | 7 | 25037231 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 1.15e-08 | 15 | 61 | 4 | 9832566 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.97e-08 | 97 | 61 | 6 | 27559042 | |
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 2.05e-08 | 4 | 61 | 3 | 8984825 | |
| Pubmed | Immunohistochemical characteristics of developing mandibular angle in fetal mice. | 2.05e-08 | 4 | 61 | 3 | 16356873 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 9880238 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 10633870 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 19932771 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 24361166 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 1409674 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 2.05e-08 | 4 | 61 | 3 | 2054384 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 8686743 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 33974636 | ||
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 16537906 | ||
| Pubmed | An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. | 5.12e-08 | 5 | 61 | 3 | 9659900 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 11973338 | ||
| Pubmed | Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells. | 5.12e-08 | 5 | 61 | 3 | 14758483 | |
| Pubmed | Extracellular matrix protein expression during mouse detrusor development. | 5.12e-08 | 5 | 61 | 3 | 12592609 | |
| Pubmed | 5.12e-08 | 5 | 61 | 3 | 19790048 | ||
| Pubmed | 8.86e-08 | 24 | 61 | 4 | 25344368 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.02e-07 | 6 | 61 | 3 | 17029294 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 15514164 | ||
| Pubmed | Development and regeneration of the neonatal digit tip in mice. | 1.02e-07 | 6 | 61 | 3 | 18234177 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 16192629 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 21467034 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 17135260 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.02e-07 | 6 | 61 | 3 | 8563024 | |
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 7813775 | ||
| Pubmed | 1.02e-07 | 6 | 61 | 3 | 16556917 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.02e-07 | 6 | 61 | 3 | 3571333 | |
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 23273220 | ||
| Pubmed | 1.79e-07 | 7 | 61 | 3 | 10072783 | ||
| Pubmed | 2.27e-07 | 146 | 61 | 6 | 27068509 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.86e-07 | 8 | 61 | 3 | 20059976 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 27664939 | ||
| Pubmed | Filamin B mutations cause chondrocyte defects in skeletal development. | 2.86e-07 | 8 | 61 | 3 | 17510210 | |
| Pubmed | Type XIII collagen strongly affects bone formation in transgenic mice. | 2.86e-07 | 8 | 61 | 3 | 16007336 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 3997552 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 15872058 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 26553654 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 2.86e-07 | 8 | 61 | 3 | 11867580 | |
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 2.86e-07 | 8 | 61 | 3 | 33875569 | |
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 9164858 | ||
| Pubmed | 2.86e-07 | 8 | 61 | 3 | 10382266 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 2.86e-07 | 8 | 61 | 3 | 10970885 | |
| Pubmed | Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia. | 2.97e-07 | 32 | 61 | 4 | 27770432 | |
| Pubmed | Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. | 4.28e-07 | 9 | 61 | 3 | 31844321 | |
| Pubmed | Collagen XXVII organises the pericellular matrix in the growth plate. | 4.28e-07 | 9 | 61 | 3 | 22206015 | |
| Pubmed | 4.28e-07 | 9 | 61 | 3 | 31199918 | ||
| Pubmed | 4.65e-07 | 87 | 61 | 5 | 20548288 | ||
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 30738849 | ||
| Pubmed | Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos. | 6.11e-07 | 10 | 61 | 3 | 15162503 | |
| Pubmed | Ucma is not necessary for normal development of the mouse skeleton. | 6.11e-07 | 10 | 61 | 3 | 22155508 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 20864640 | ||
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 9415455 | ||
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 2446864 | ||
| Pubmed | VEGF stimulates intramembranous bone formation during craniofacial skeletal development. | 6.11e-07 | 10 | 61 | 3 | 26899202 | |
| Pubmed | Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. | 6.11e-07 | 10 | 61 | 3 | 16109715 | |
| Pubmed | 6.73e-07 | 39 | 61 | 4 | 33580754 | ||
| Pubmed | 6.73e-07 | 39 | 61 | 4 | 30566624 | ||
| Pubmed | Global defects in collagen secretion in a Mia3/TANGO1 knockout mouse. | 6.73e-07 | 39 | 61 | 4 | 21606205 | |
| Pubmed | Hsp and chaperone distribution during endochondral bone development in mouse embryo. | 8.39e-07 | 11 | 61 | 3 | 9880236 | |
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 8.39e-07 | 11 | 61 | 3 | 20696843 | |
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 2745554 | ||
| Pubmed | Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. | 8.39e-07 | 11 | 61 | 3 | 15101818 | |
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 35988140 | ||
| Pubmed | 8.39e-07 | 11 | 61 | 3 | 24248941 | ||
| Pubmed | 9.39e-07 | 186 | 61 | 6 | 20673868 | ||
| Pubmed | 9.39e-07 | 186 | 61 | 6 | 20452482 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.12e-06 | 12 | 61 | 3 | 12180907 | |
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 32002646 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.21e-06 | 45 | 61 | 4 | 34248495 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 1.45e-06 | 13 | 61 | 3 | 11839810 | |
| Pubmed | 1.45e-06 | 13 | 61 | 3 | 31961823 | ||
| Pubmed | EGR1 and EGR2 involvement in vertebrate tendon differentiation. | 1.45e-06 | 13 | 61 | 3 | 21173153 | |
| Interaction | LAIR2 interactions | 1.13e-10 | 49 | 60 | 7 | int:LAIR2 | |
| Interaction | MMP2 interactions | 1.85e-10 | 87 | 60 | 8 | int:MMP2 | |
| Interaction | MMP9 interactions | 4.67e-08 | 67 | 60 | 6 | int:MMP9 | |
| Interaction | C1QTNF1 interactions | 2.75e-07 | 47 | 60 | 5 | int:C1QTNF1 | |
| Interaction | TGFBI interactions | 8.57e-07 | 25 | 60 | 4 | int:TGFBI | |
| Interaction | SPARC interactions | 1.42e-06 | 65 | 60 | 5 | int:SPARC | |
| Interaction | BGN interactions | 1.84e-06 | 30 | 60 | 4 | int:BGN | |
| Interaction | PDGFA interactions | 2.40e-06 | 32 | 60 | 4 | int:PDGFA | |
| Interaction | COL1A2 interactions | 3.53e-06 | 78 | 60 | 5 | int:COL1A2 | |
| Interaction | COL8A2 interactions | 7.30e-06 | 42 | 60 | 4 | int:COL8A2 | |
| Interaction | CD93 interactions | 9.65e-06 | 45 | 60 | 4 | int:CD93 | |
| Interaction | FGF7 interactions | 1.37e-05 | 16 | 60 | 3 | int:FGF7 | |
| Interaction | CBLL2 interactions | 2.76e-05 | 20 | 60 | 3 | int:CBLL2 | |
| Interaction | OSM interactions | 2.76e-05 | 20 | 60 | 3 | int:OSM | |
| Interaction | COL5A2 interactions | 8.68e-05 | 29 | 60 | 3 | int:COL5A2 | |
| Interaction | MAG interactions | 8.68e-05 | 29 | 60 | 3 | int:MAG | |
| Interaction | VWF interactions | 1.17e-04 | 32 | 60 | 3 | int:VWF | |
| Interaction | FKBP9 interactions | 1.31e-04 | 87 | 60 | 4 | int:FKBP9 | |
| Interaction | PDGFB interactions | 1.37e-04 | 88 | 60 | 4 | int:PDGFB | |
| Interaction | TNKS interactions | 2.71e-04 | 105 | 60 | 4 | int:TNKS | |
| Interaction | PEG10 interactions | 2.81e-04 | 106 | 60 | 4 | int:PEG10 | |
| Interaction | DCN interactions | 2.84e-04 | 43 | 60 | 3 | int:DCN | |
| Interaction | SMAD3 interactions | 3.53e-04 | 447 | 60 | 7 | int:SMAD3 | |
| Interaction | COL4A1 interactions | 3.94e-04 | 48 | 60 | 3 | int:COL4A1 | |
| Interaction | PCOLCE interactions | 4.71e-04 | 11 | 60 | 2 | int:PCOLCE | |
| Interaction | C1QTNF9B interactions | 4.72e-04 | 51 | 60 | 3 | int:C1QTNF9B | |
| Interaction | PAX3 interactions | 5.00e-04 | 52 | 60 | 3 | int:PAX3 | |
| Interaction | SMAD7 interactions | 5.58e-04 | 127 | 60 | 4 | int:SMAD7 | |
| Interaction | THBS1 interactions | 5.58e-04 | 127 | 60 | 4 | int:THBS1 | |
| Interaction | HTRA1 interactions | 5.59e-04 | 54 | 60 | 3 | int:HTRA1 | |
| GeneFamily | Collagens | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 8.14e-16 | 46 | 42 | 9 | 490 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 5.73e-16 | 43 | 61 | 9 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 7.19e-16 | 44 | 61 | 9 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.24e-08 | 270 | 61 | 9 | MM17057 |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.26e-08 | 120 | 61 | 7 | M42505 | |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL3A1 COL4A2 COL4A6 COL5A2 COL7A1 COL27A1 COL1A1 COL1A2 | 1.46e-08 | 275 | 61 | 9 | M5884 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 1.17e-07 | 99 | 61 | 6 | M39152 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | COL3A1 XYLT1 COL4A2 COLEC12 COL5A2 SSPN ARHGEF40 COL1A1 COL1A2 | 1.20e-07 | 352 | 61 | 9 | M17471 |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.17e-07 | 192 | 61 | 7 | M42501 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 6.04e-07 | 29 | 61 | 4 | MM17055 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 8.22e-07 | 74 | 61 | 5 | M13547 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.29e-06 | 81 | 61 | 5 | M39253 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.32e-06 | 35 | 61 | 4 | MM17054 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.95e-06 | 88 | 61 | 5 | M1167 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT | 2.18e-06 | 90 | 61 | 5 | M38984 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.30e-06 | 91 | 61 | 5 | M40180 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.47e-06 | 261 | 61 | 7 | M1834 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A2 COL4A6 ERFE COLEC12 COL5A2 COL7A1 COL27A1 PLXNA1 COL1A1 COL1A2 | 3.00e-06 | 1008 | 61 | 12 | MM17056 |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 3.36e-06 | 44 | 61 | 4 | M18274 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 3.67e-06 | 100 | 61 | 5 | MM514 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 4.39e-06 | 47 | 61 | 4 | M7585 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 4.78e-06 | 48 | 61 | 4 | M39318 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 6.02e-06 | 194 | 61 | 6 | M39122 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 7.17e-06 | 200 | 61 | 6 | M5930 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 8.65e-06 | 316 | 61 | 7 | M2293 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 9.55e-06 | 18 | 61 | 3 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 9.55e-06 | 18 | 61 | 3 | M13796 | |
| Coexpression | PASINI_SUZ12_TARGETS_DN | 9.97e-06 | 323 | 61 | 7 | MM1066 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 1.03e-05 | 58 | 61 | 4 | M178 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.13e-05 | 19 | 61 | 3 | M15125 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.52e-05 | 64 | 61 | 4 | M2572 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 1.62e-05 | 65 | 61 | 4 | M39309 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.70e-05 | 137 | 61 | 5 | M40313 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.82e-05 | 493 | 61 | 8 | M19391 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.93e-05 | 68 | 61 | 4 | M1373 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.05e-05 | 69 | 61 | 4 | M10165 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.05e-05 | 23 | 61 | 3 | M48001 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 2.16e-05 | 505 | 61 | 8 | M39167 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 2.17e-05 | 144 | 61 | 5 | M5942 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL3A1 COL4A2 COL4A6 COLEC12 COL5A2 COL7A1 COL27A1 PLXNA1 COL1A1 COL1A2 | 2.18e-05 | 1026 | 61 | 11 | M5889 |
| Coexpression | GU_PDEF_TARGETS_UP | 2.30e-05 | 71 | 61 | 4 | M3955 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.43e-05 | 72 | 61 | 4 | MM1131 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 2.70e-05 | 74 | 61 | 4 | M4479 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 2.96e-05 | 257 | 61 | 6 | M13867 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.08e-05 | 385 | 61 | 7 | M39264 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.50e-05 | 79 | 61 | 4 | M18400 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.68e-05 | 80 | 61 | 4 | MM1285 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_DN | 3.93e-05 | 163 | 61 | 5 | M2769 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS | 4.05e-05 | 82 | 61 | 4 | M39274 | |
| Coexpression | NAKAMURA_CANCER_MICROENVIRONMENT_UP | 4.20e-05 | 29 | 61 | 3 | M7581 | |
| Coexpression | ZHU_CMV_24_HR_DN | 4.46e-05 | 84 | 61 | 4 | M4065 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 7.17e-05 | 185 | 61 | 5 | M42503 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.44e-05 | 35 | 61 | 3 | M11788 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 7.67e-05 | 305 | 61 | 6 | M19875 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 7.94e-05 | 6 | 61 | 2 | M48000 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.11e-05 | 36 | 61 | 3 | MM1212 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 ERFE CRACD COL5A2 ARHGEF40 KIF26A COL27A1 APC2 KNDC1 FAM83G SHISA8 | 9.06e-05 | 1201 | 61 | 11 | M4391 |
| Coexpression | GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP | 9.87e-05 | 198 | 61 | 5 | M3131 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN | 1.01e-04 | 199 | 61 | 5 | M9832 | |
| Coexpression | GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP | 1.03e-04 | 200 | 61 | 5 | M4305 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP | 1.08e-04 | 202 | 61 | 5 | M38982 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.11e-04 | 40 | 61 | 3 | M1574 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.32e-04 | 337 | 61 | 6 | MM16606 | |
| Coexpression | JONES_OVARY_THECA | 1.70e-04 | 46 | 61 | 3 | M48349 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.70e-04 | 46 | 61 | 3 | MM670 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.70e-04 | 46 | 61 | 3 | MM544 | |
| Coexpression | ZHU_CMV_ALL_DN | 1.73e-04 | 119 | 61 | 4 | M14555 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.74e-04 | 681 | 61 | 8 | M39175 | |
| Coexpression | KHETCHOUMIAN_TRIM24_TARGETS_UP | 1.81e-04 | 47 | 61 | 3 | M1399 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD | 1.81e-04 | 47 | 61 | 3 | M38990 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 1.83e-04 | 226 | 61 | 5 | M11238 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 1.95e-04 | 229 | 61 | 5 | MM16607 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 2.04e-04 | 365 | 61 | 6 | M39018 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 2.05e-04 | 49 | 61 | 3 | M2899 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.15e-04 | 126 | 61 | 4 | M39132 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 2.17e-04 | 50 | 61 | 3 | MM403 | |
| Coexpression | SEMBA_FHIT_TARGETS_UP | 2.89e-04 | 11 | 61 | 2 | M14812 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 3.30e-04 | 141 | 61 | 4 | M10381 | |
| Coexpression | DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS | 3.38e-04 | 58 | 61 | 3 | M40256 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 3.39e-04 | 567 | 61 | 7 | M2129 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 3.58e-04 | 144 | 61 | 4 | M1484 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | COL3A1 COL4A2 COL5A2 ARHGEF40 COL27A1 HNRNPM PRPF40A PLXNA1 GTF3C4 COL1A1 COL1A2 | 3.60e-04 | 1407 | 61 | 11 | M14427 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.73e-04 | 60 | 61 | 3 | M1950 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 3.77e-04 | 146 | 61 | 4 | MM973 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP | 3.87e-04 | 147 | 61 | 4 | M6765 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 3.88e-04 | 767 | 61 | 8 | M39209 | |
| Coexpression | POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN | 3.92e-04 | 61 | 61 | 3 | M8510 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 3.97e-04 | 148 | 61 | 4 | MM1010 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 4.11e-04 | 62 | 61 | 3 | MM829 | |
| Coexpression | WILCOX_RESPONSE_TO_PROGESTERONE_DN | 4.11e-04 | 62 | 61 | 3 | M16774 | |
| Coexpression | BENPORATH_NANOG_TARGETS | COL4A6 COL7A1 KIF26A ZNF185 TCEAL8 HNRNPUL1 SSBP3 TAF12 GTF3C4 | 4.41e-04 | 988 | 61 | 9 | M6616 |
| Coexpression | HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS | 5.49e-04 | 15 | 61 | 2 | MM402 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.58e-04 | 162 | 61 | 4 | M45037 | |
| Coexpression | DEMAGALHAES_AGING_DN | 6.26e-04 | 16 | 61 | 2 | M2145 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 6.69e-04 | 300 | 61 | 5 | M41708 | |
| Coexpression | DURAND_STROMA_S_UP | 6.69e-04 | 300 | 61 | 5 | M2581 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 7.00e-04 | 303 | 61 | 5 | M39040 | |
| Coexpression | KANG_AR_TARGETS_UP | 7.08e-04 | 17 | 61 | 2 | MM1297 | |
| Coexpression | KANG_AR_TARGETS_UP | 7.08e-04 | 17 | 61 | 2 | M2223 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 7.08e-04 | 17 | 61 | 2 | M47995 | |
| Coexpression | DURAND_STROMA_S_UP | 7.10e-04 | 304 | 61 | 5 | MM1083 | |
| CoexpressionAtlas | BM Top 100 - cervix | 1.19e-06 | 66 | 60 | 5 | BM Top 100 - cervix | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.19e-06 | 66 | 60 | 5 | BM Top 100 - endometrium | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL2A1 COL3A1 ALX3 COL4A2 RAB36 COLEC12 COL5A2 ZNF469 NKD2 APC2 SERTAD4 SORCS2 COL1A1 COL1A2 | 1.60e-06 | 1094 | 60 | 14 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.97e-06 | 369 | 60 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 3.03e-05 | 213 | 60 | 6 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 3.03e-05 | 213 | 60 | 6 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | COL2A1 COL3A1 RAB36 COL5A2 IQSEC3 NKD2 SERTAD4 COL1A1 COL1A2 | 3.83e-05 | 589 | 60 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 4.34e-05 | 69 | 60 | 4 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 4.59e-05 | 70 | 60 | 4 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.84e-05 | 607 | 60 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 5.13e-05 | 72 | 60 | 4 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 5.42e-05 | 73 | 60 | 4 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 5.72e-05 | 74 | 60 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 5.72e-05 | 74 | 60 | 4 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.44e-05 | 642 | 60 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 8.38e-05 | 652 | 60 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.40e-04 | 281 | 60 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.40e-04 | 281 | 60 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.64e-04 | 97 | 60 | 4 | GSM777043_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.85e-04 | 567 | 60 | 8 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.89e-04 | 726 | 60 | 9 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.98e-04 | 731 | 60 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.05e-04 | 734 | 60 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 2.07e-04 | 103 | 60 | 4 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.26e-04 | 744 | 60 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.46e-04 | 591 | 60 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.60e-04 | 596 | 60 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K2 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#5 | 3.26e-04 | 116 | 60 | 4 | ratio_EB_vs_SC_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | COL2A1 ALX3 XYLT1 IQSEC3 KLF13 ZNF185 SORCS2 KNDC1 ZNF579 PRPF40A | 3.83e-04 | 979 | 60 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | COL2A1 CRACD COL7A1 KLF13 APC2 ZNF579 PCDH9 PLXNA1 COL1A1 COL1A2 | 3.99e-04 | 984 | 60 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.88e-04 | 655 | 60 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.22e-04 | 834 | 60 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 5.82e-04 | 240 | 60 | 5 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | BM Top 100 - myometrium | 8.27e-04 | 65 | 60 | 3 | BM Top 100 - myometrium | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.65e-04 | 66 | 60 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k3_1000 | |
| CoexpressionAtlas | BM Top 100 - colon cecum | 9.43e-04 | 68 | 60 | 3 | BM Top 100 - colon cecum | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.01e-03 | 408 | 60 | 6 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | BM Top 100 - ovary | 1.03e-03 | 70 | 60 | 3 | BM Top 100 - ovary | |
| CoexpressionAtlas | BM Top 100 - stomach fundus | 1.07e-03 | 71 | 60 | 3 | BM Top 100 - stomach fundus | |
| CoexpressionAtlas | BM Top 100 - stomach cardiac | 1.11e-03 | 72 | 60 | 3 | BM Top 100 - stomach cardiac | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.14e-03 | 279 | 60 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K2 | |
| CoexpressionAtlas | BM Top 100 - vagina | 1.30e-03 | 76 | 60 | 3 | BM Top 100 - vagina | |
| CoexpressionAtlas | BM Top 100 - urethra | 1.35e-03 | 77 | 60 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.38e-03 | 769 | 60 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.40e-03 | 78 | 60 | 3 | PCBC_ratio_DE_from-OSKM_vs_DE_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.48e-03 | 967 | 60 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 1.49e-03 | 778 | 60 | 8 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.53e-03 | 298 | 60 | 5 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.55e-03 | 176 | 60 | 4 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.58e-03 | 445 | 60 | 6 | GSM777043_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.60e-03 | 978 | 60 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | BM Top 100 - vulva | 1.62e-03 | 82 | 60 | 3 | BM Top 100 - vulva | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 1.65e-03 | 791 | 60 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 1.74e-03 | 84 | 60 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.76e-03 | 455 | 60 | 6 | GSM777055_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | COL2A1 COL3A1 ALX3 COLEC12 COL5A2 SERTAD4 SORCS2 COL1A1 COL1A2 | 1.79e-03 | 994 | 60 | 9 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.80e-03 | 85 | 60 | 3 | GSM777067_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.82e-03 | 310 | 60 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 1.86e-03 | 86 | 60 | 3 | GSM777055_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.92e-03 | 87 | 60 | 3 | GSM777050_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.99e-03 | 466 | 60 | 6 | GSM777050_500 | |
| CoexpressionAtlas | e9.5_NeuroEpith_OverFaceMesench_top-relative-expression-ranked_500_5 | 2.08e-03 | 24 | 60 | 2 | Facebase_ST1_e9.5_NeuroEpith_OverFaceMesench_500_5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.09e-03 | 191 | 60 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | COL3A1 XYLT1 COLEC12 COL5A2 NKD2 COL27A1 SORCS2 COL1A1 COL1A2 | 5.07e-12 | 190 | 61 | 9 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-10 | 180 | 61 | 8 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-10 | 188 | 61 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-10 | 189 | 61 | 8 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.03e-10 | 189 | 61 | 8 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.12e-10 | 190 | 61 | 8 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-10 | 191 | 61 | 8 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-10 | 192 | 61 | 8 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-10 | 192 | 61 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-10 | 192 | 61 | 8 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.61e-10 | 195 | 61 | 8 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-10 | 197 | 61 | 8 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-10 | 197 | 61 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-10 | 197 | 61 | 8 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-10 | 197 | 61 | 8 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.94e-10 | 198 | 61 | 8 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.77e-10 | 134 | 61 | 7 | b959899c89d3a0363a3cd2309155280e0fe5ba88 | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-09 | 142 | 61 | 7 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-09 | 159 | 61 | 7 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.24e-09 | 159 | 61 | 7 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.78e-09 | 164 | 61 | 7 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-09 | 169 | 61 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.42e-09 | 169 | 61 | 7 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.91e-09 | 178 | 61 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.91e-09 | 178 | 61 | 7 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-09 | 181 | 61 | 7 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-09 | 181 | 61 | 7 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-09 | 183 | 61 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-09 | 183 | 61 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-09 | 183 | 61 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 6.18e-09 | 184 | 61 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.41e-09 | 185 | 61 | 7 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.41e-09 | 185 | 61 | 7 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.91e-09 | 187 | 61 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.91e-09 | 187 | 61 | 7 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-09 | 192 | 61 | 7 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-09 | 192 | 61 | 7 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.29e-09 | 192 | 61 | 7 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-09 | 192 | 61 | 7 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-09 | 192 | 61 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-09 | 192 | 61 | 7 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.91e-09 | 194 | 61 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.91e-09 | 194 | 61 | 7 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.91e-09 | 194 | 61 | 7 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-09 | 195 | 61 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-09 | 195 | 61 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.23e-09 | 195 | 61 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-09 | 195 | 61 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-09 | 195 | 61 | 7 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 9.56e-09 | 196 | 61 | 7 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-09 | 196 | 61 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-09 | 196 | 61 | 7 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-09 | 196 | 61 | 7 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-09 | 196 | 61 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-09 | 196 | 61 | 7 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.56e-09 | 196 | 61 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-09 | 196 | 61 | 7 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 9.90e-09 | 197 | 61 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-09 | 197 | 61 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-09 | 197 | 61 | 7 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-09 | 197 | 61 | 7 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 9.90e-09 | 197 | 61 | 7 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 198 | 61 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-08 | 198 | 61 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-08 | 198 | 61 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-08 | 198 | 61 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-08 | 198 | 61 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.03e-08 | 198 | 61 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.06e-08 | 199 | 61 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.06e-08 | 199 | 61 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-08 | 199 | 61 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-08 | 199 | 61 | 7 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-08 | 199 | 61 | 7 | edd5300da1a3b758210ff8f949e9d1988b8bc7e2 | |
| ToppCell | proximal-3-mesenchymal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-08 | 200 | 61 | 7 | 94250991f78ea56810412d00a4bb645eb975478c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-08 | 200 | 61 | 7 | 8b80811a0ec28d1d763c10b095d1969bccbe82d4 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-08 | 200 | 61 | 7 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuroepithelial-Proteoglycan-expressing_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-08 | 200 | 61 | 7 | 52ec80f3922ae6ee3565d5993c2fc56bb3a3199a | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-08 | 200 | 61 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 1.10e-08 | 200 | 61 | 7 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.10e-08 | 200 | 61 | 7 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.10e-08 | 200 | 61 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | proximal-mesenchymal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.10e-08 | 200 | 61 | 7 | 29f3a5c85404c6537d6405d599ebae281e0d4d4f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.93e-08 | 154 | 61 | 6 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-08 | 156 | 61 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.48e-08 | 156 | 61 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 8.38e-08 | 159 | 61 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-07 | 165 | 61 | 6 | 570483b43ccb5831feec9337b4664814431d40b1 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_TIP|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.04e-07 | 165 | 61 | 6 | 2026a9a07f4d314cc05c167e491312b373468e46 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-07 | 165 | 61 | 6 | f80665b75d43f1bf6919d59fc762e7e0bac653f2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-07 | 167 | 61 | 6 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-07 | 167 | 61 | 6 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.12e-07 | 167 | 61 | 6 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.16e-07 | 168 | 61 | 6 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-07 | 168 | 61 | 6 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-07 | 171 | 61 | 6 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| Computational | Neighborhood of CDH11 | 8.90e-07 | 25 | 33 | 4 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 4.05e-06 | 36 | 33 | 4 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.53e-05 | 50 | 33 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.53e-05 | 50 | 33 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | ECM and collagens. | 5.43e-05 | 225 | 33 | 6 | MODULE_47 | |
| Computational | Adhesion molecules. | 6.39e-05 | 141 | 33 | 5 | MODULE_122 | |
| Computational | Genes in the cancer module 55. | 6.75e-04 | 832 | 33 | 9 | MODULE_55 | |
| Drug | GK-101 | 4.83e-12 | 36 | 60 | 7 | CID000161853 | |
| Drug | Madecassol | 3.04e-11 | 46 | 60 | 7 | CID000108062 | |
| Drug | Collagenase | 4.36e-11 | 4 | 60 | 4 | DB00048 | |
| Drug | d-indobufen | 5.62e-11 | 50 | 60 | 7 | CID000044562 | |
| Drug | ridogrel | 7.50e-11 | 52 | 60 | 7 | CID005362391 | |
| Drug | NSC49633 | 8.62e-11 | 53 | 60 | 7 | CID000023340 | |
| Drug | AC1LAKND | 2.70e-10 | 62 | 60 | 7 | CID000470146 | |
| Drug | BAPN | 7.17e-10 | 71 | 60 | 7 | CID000001647 | |
| Drug | malotilate | 7.17e-10 | 71 | 60 | 7 | CID000004006 | |
| Drug | AC1NMZ1B | 1.06e-09 | 75 | 60 | 7 | CID005034185 | |
| Drug | strontium ranelate | 1.28e-09 | 77 | 60 | 7 | CID006918182 | |
| Drug | halofuginone lactate | 2.59e-09 | 85 | 60 | 7 | CID000062891 | |
| Drug | 4-hydroxyproline | 4.19e-09 | 91 | 60 | 7 | CID000000825 | |
| Drug | ticlopidine | 1.00e-08 | 103 | 60 | 7 | CID000005472 | |
| Drug | hydroxylysine | 1.49e-08 | 109 | 60 | 7 | CID000001029 | |
| Drug | AC1L1C2F | 1.58e-08 | 110 | 60 | 7 | CID000001711 | |
| Drug | PPACK | 1.91e-08 | 113 | 60 | 7 | CID003036757 | |
| Drug | AC1L9732 | 2.03e-08 | 114 | 60 | 7 | CID000439300 | |
| Drug | Tranilast sodium | 2.16e-08 | 115 | 60 | 7 | CID000005527 | |
| Drug | isodesmosine | 2.40e-08 | 33 | 60 | 5 | CID000013811 | |
| Drug | foscarnet | 3.58e-08 | 190 | 60 | 8 | CID000003414 | |
| Drug | Selara | 3.85e-08 | 125 | 60 | 7 | CID000150310 | |
| Drug | DMSe | 5.61e-08 | 132 | 60 | 7 | CID000020796 | |
| Drug | ascorbate-2-phosphate | 5.82e-08 | 15 | 60 | 4 | ctd:C011669 | |
| Drug | pirfenidone | 7.62e-08 | 138 | 60 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 8.01e-08 | 139 | 60 | 7 | CID000004727 | |
| Drug | PCR 4099 | 8.01e-08 | 139 | 60 | 7 | CID000002806 | |
| Drug | candesartan cilexetil | 1.07e-07 | 145 | 60 | 7 | CID000002540 | |
| Drug | 351A | 2.05e-07 | 20 | 60 | 4 | CID000122144 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 2.28e-07 | 162 | 60 | 7 | CID000072363 | |
| Drug | desmosine | 2.79e-07 | 53 | 60 | 5 | CID000025435 | |
| Drug | khellin | 3.29e-07 | 171 | 60 | 7 | CID000003828 | |
| Drug | BPAT-143 | 3.46e-07 | 6 | 60 | 3 | CID000146249 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 3.46e-07 | 6 | 60 | 3 | ctd:C502971 | |
| Drug | AC1L1DD6 | 4.49e-07 | 179 | 60 | 7 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 6.47e-07 | 189 | 60 | 7 | CID000001413 | |
| Drug | silibinin | 7.96e-07 | 285 | 60 | 8 | CID000005213 | |
| Drug | 4-aminoazobenzene | 8.47e-07 | 66 | 60 | 5 | CID000006051 | |
| Drug | chondroitin sulfate | COL2A1 COL3A1 XYLT1 COL4A6 COL7A1 NEU4 COL27A1 COL1A1 COL1A2 | 1.27e-06 | 413 | 60 | 9 | CID000024766 |
| Drug | L-3,4-dehydroproline | 1.40e-06 | 73 | 60 | 5 | CID000094284 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.64e-06 | 314 | 60 | 8 | CID000447989 | |
| Drug | Sirius red | 2.15e-06 | 35 | 60 | 4 | CID005486818 | |
| Drug | AC1Q6PCP | 2.40e-06 | 230 | 60 | 7 | CID000005267 | |
| Drug | AC1MRIIV | 3.34e-06 | 39 | 60 | 4 | CID003518584 | |
| Drug | AC1L1KMJ | COL2A1 COL3A1 COL4A6 COLEC12 COL7A1 COL27A1 APC2 COL1A1 COL1A2 | 4.06e-06 | 476 | 60 | 9 | CID000030956 |
| Drug | prostacyclin sodium salt | 4.16e-06 | 250 | 60 | 7 | CID000000159 | |
| Drug | PD123177 | 4.98e-06 | 43 | 60 | 4 | CID000114899 | |
| Drug | NC-4 | 5.47e-06 | 44 | 60 | 4 | CID006420119 | |
| Drug | hyaluronan | 5.80e-06 | 263 | 60 | 7 | CID000024759 | |
| Drug | pyridinoline | 6.34e-06 | 99 | 60 | 5 | CID000105068 | |
| Drug | losartan | 6.46e-06 | 378 | 60 | 8 | CID000003961 | |
| Drug | 5'-methylthioadenosine | 6.83e-06 | 2 | 60 | 2 | ctd:C008500 | |
| Drug | colchine | 7.11e-06 | 383 | 60 | 8 | CID000002833 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | 1.04e-05 | 189 | 60 | 6 | 4464_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; PC3; HT_HG-U133A | 1.36e-05 | 198 | 60 | 6 | 4462_UP | |
| Drug | trapidil | 1.55e-05 | 57 | 60 | 4 | CID000005531 | |
| Drug | AC1Q641C | 2.17e-05 | 62 | 60 | 4 | CID000005005 | |
| Drug | AC1L18QD | 2.29e-05 | 325 | 60 | 7 | CID000000213 | |
| Drug | diacetylrhein | 4.08e-05 | 4 | 60 | 2 | ctd:C025292 | |
| Drug | ATFP | 4.08e-05 | 4 | 60 | 2 | CID000193783 | |
| Drug | N-acetyl-4-benzoquinoneimine | 5.11e-05 | 77 | 60 | 4 | ctd:C028473 | |
| Drug | homocystine | 6.54e-05 | 82 | 60 | 4 | CID000010010 | |
| Drug | Saralasin | 6.79e-05 | 5 | 60 | 2 | ctd:D012504 | |
| Drug | carbosulfan | 9.00e-05 | 89 | 60 | 4 | CID000041384 | |
| Drug | (1S,2R)-1-amino-1-thiazolidin-2-yl-propan-2-ol | 9.40e-05 | 90 | 60 | 4 | CID015942693 | |
| Drug | cyanogen-bromide | 9.82e-05 | 34 | 60 | 3 | CID000010476 | |
| Drug | Diphosphonates | 1.02e-04 | 6 | 60 | 2 | ctd:D004164 | |
| Drug | AG-H-50319 | 1.02e-04 | 6 | 60 | 2 | CID011819195 | |
| Drug | AC1L9HPX | 1.02e-04 | 92 | 60 | 4 | CID000445279 | |
| Drug | aspirin | 1.10e-04 | 563 | 60 | 8 | CID000002244 | |
| Drug | AC1L3XKP | 1.27e-04 | 37 | 60 | 3 | CID000123931 | |
| Drug | deoxypyridinoline | 1.31e-04 | 98 | 60 | 4 | CID000105071 | |
| Drug | ammonium perchlorate | 1.42e-04 | 7 | 60 | 2 | ctd:C053506 | |
| Drug | retinyl beta-glucuronide | 1.42e-04 | 7 | 60 | 2 | CID006440956 | |
| Drug | neo-gambogic acid | 1.42e-04 | 7 | 60 | 2 | ctd:C045863 | |
| Drug | Oi-1 | 1.42e-04 | 7 | 60 | 2 | CID000448053 | |
| Drug | Tungsten Compounds | 1.47e-04 | 101 | 60 | 4 | ctd:D017973 | |
| Drug | AC1L9N61 | 1.53e-04 | 102 | 60 | 4 | CID000449471 | |
| Drug | Y-27632 | 1.62e-04 | 444 | 60 | 7 | CID000005711 | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 3745_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 3571_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 4446_UP | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 4202_UP | |
| Drug | HHMD | 1.89e-04 | 8 | 60 | 2 | CID000171068 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 1.89e-04 | 8 | 60 | 2 | ctd:C000594958 | |
| Drug | Sialic acids | 2.26e-04 | 329 | 60 | 6 | CID000349960 | |
| Drug | Ambroxol | 2.43e-04 | 9 | 60 | 2 | ctd:D000551 | |
| Drug | azelastine | 2.43e-04 | 9 | 60 | 2 | ctd:C020976 | |
| Drug | 4-hydroxymercuribenzoate | 2.43e-04 | 9 | 60 | 2 | ctd:C030601 | |
| Drug | dermatan sulfate | 2.85e-04 | 220 | 60 | 5 | CID000032756 | |
| Drug | LMWH | 3.34e-04 | 663 | 60 | 8 | CID000000772 | |
| Drug | enterotoxin C, staphylococcal | 3.70e-04 | 11 | 60 | 2 | ctd:C034959 | |
| Drug | AC1L1TXN | 3.92e-04 | 54 | 60 | 3 | CID000060791 | |
| Drug | glycyl-L-leucine | 3.92e-04 | 54 | 60 | 3 | CID000092843 | |
| Drug | Rgd Peptide | 4.17e-04 | 239 | 60 | 5 | CID000104802 | |
| Drug | ligustrazine | 4.37e-04 | 56 | 60 | 3 | CID000014296 | |
| Drug | monomethylarsonic acid | 4.37e-04 | 56 | 60 | 3 | CID000008947 | |
| Drug | 1h00 | 4.37e-04 | 56 | 60 | 3 | CID000445950 | |
| Drug | V2O5 | 4.60e-04 | 57 | 60 | 3 | CID000014814 | |
| Disease | Ehlers-Danlos Syndrome | 7.57e-08 | 5 | 59 | 3 | C0013720 | |
| Disease | Ehlers-Danlos syndrome | 4.22e-07 | 8 | 59 | 3 | cv:C0013720 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 6.32e-07 | 9 | 59 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.92e-06 | 53 | 59 | 4 | C4707243 | |
| Disease | osteogenesis imperfecta type 3 (is_implicated_in) | 3.93e-06 | 2 | 59 | 2 | DOID:0110339 (is_implicated_in) | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 3.93e-06 | 2 | 59 | 2 | C0268345 | |
| Disease | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 3.93e-06 | 2 | 59 | 2 | C4551623 | |
| Disease | osteogenesis imperfecta type 4 (is_implicated_in) | 3.93e-06 | 2 | 59 | 2 | DOID:0110340 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 2 (is_implicated_in) | 3.93e-06 | 2 | 59 | 2 | DOID:0110341 (is_implicated_in) | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE IV | 3.93e-06 | 2 | 59 | 2 | 166220 | |
| Disease | Osteogenesis imperfecta with normal sclerae, dominant form | 3.93e-06 | 2 | 59 | 2 | cv:C0268363 | |
| Disease | Osteogenesis imperfecta type III | 3.93e-06 | 2 | 59 | 2 | cv:C0268362 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE II | 3.93e-06 | 2 | 59 | 2 | 166210 | |
| Disease | Osteogenesis imperfecta, perinatal lethal | 3.93e-06 | 2 | 59 | 2 | cv:C0268358 | |
| Disease | OSTEOGENESIS IMPERFECTA, TYPE III | 3.93e-06 | 2 | 59 | 2 | 259420 | |
| Disease | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 1.18e-05 | 3 | 59 | 2 | C4552122 | |
| Disease | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1.18e-05 | 3 | 59 | 2 | C0220679 | |
| Disease | osteogenesis imperfecta (is_implicated_in) | 1.18e-05 | 3 | 59 | 2 | DOID:12347 (is_implicated_in) | |
| Disease | osteogenesis imperfecta type 3 (implicated_via_orthology) | 1.18e-05 | 3 | 59 | 2 | DOID:0110339 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations (is_implicated_in) | 2.35e-05 | 4 | 59 | 2 | DOID:0090131 (is_implicated_in) | |
| Disease | OSTEOPOROSIS | 2.35e-05 | 4 | 59 | 2 | 166710 | |
| Disease | Osteogenesis imperfecta, dominant perinatal lethal | 3.92e-05 | 5 | 59 | 2 | C0268358 | |
| Disease | osteogenesis imperfecta (implicated_via_orthology) | 3.92e-05 | 5 | 59 | 2 | DOID:12347 (implicated_via_orthology) | |
| Disease | Lobstein Disease | 3.92e-05 | 5 | 59 | 2 | C0023931 | |
| Disease | Liver Cirrhosis | 5.50e-05 | 103 | 59 | 4 | C0023890 | |
| Disease | Osteoporosis | 5.87e-05 | 6 | 59 | 2 | cv:C0029456 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 5.87e-05 | 6 | 59 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Fibrosis, Liver | 5.93e-05 | 105 | 59 | 4 | C0239946 | |
| Disease | Early Pregnancy Loss | 6.86e-05 | 109 | 59 | 4 | C3830362 | |
| Disease | Miscarriage | 6.86e-05 | 109 | 59 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 6.86e-05 | 109 | 59 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 6.86e-05 | 109 | 59 | 4 | C0000822 | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 8.20e-05 | 7 | 59 | 2 | C1846545 | |
| Disease | Bleeding tendency | 8.20e-05 | 7 | 59 | 2 | C1458140 | |
| Disease | Fibrosis | 1.39e-04 | 50 | 59 | 3 | C0016059 | |
| Disease | Cirrhosis | 1.39e-04 | 50 | 59 | 3 | C1623038 | |
| Disease | bladder neck obstruction (biomarker_via_orthology) | 1.40e-04 | 9 | 59 | 2 | DOID:13948 (biomarker_via_orthology) | |
| Disease | Osteogenesis imperfecta type IV (disorder) | 1.75e-04 | 10 | 59 | 2 | C0268363 | |
| Disease | Nephrosclerosis | 2.14e-04 | 11 | 59 | 2 | C0027719 | |
| Disease | Aortic Valve Insufficiency | 2.14e-04 | 11 | 59 | 2 | C0003504 | |
| Disease | Osteogenesis imperfecta type III (disorder) | 2.14e-04 | 11 | 59 | 2 | C0268362 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 2.56e-04 | 12 | 59 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Osteogenesis Imperfecta | 3.02e-04 | 13 | 59 | 2 | C0029434 | |
| Disease | PR interval | 4.59e-04 | 495 | 59 | 6 | EFO_0004462 | |
| Disease | Blood Coagulation Disorders | 4.63e-04 | 16 | 59 | 2 | C0005779 | |
| Disease | Oral Submucous Fibrosis | 5.89e-04 | 18 | 59 | 2 | C0029172 | |
| Disease | dense area measurement, mammographic density measurement | 6.58e-04 | 19 | 59 | 2 | EFO_0005941, EFO_0006503 | |
| Disease | Osteogenesis imperfecta | 8.05e-04 | 21 | 59 | 2 | cv:C0029434 | |
| Disease | Liver Cirrhosis, Experimental | 8.68e-04 | 774 | 59 | 7 | C0023893 | |
| Disease | Left Ventricular Hypertrophy | 1.14e-03 | 25 | 59 | 2 | C0149721 | |
| Disease | age at menarche | 1.18e-03 | 594 | 59 | 6 | EFO_0004703 | |
| Disease | Heart valve disease | 1.24e-03 | 26 | 59 | 2 | C0018824 | |
| Disease | cortical surface area measurement | 1.33e-03 | 1345 | 59 | 9 | EFO_0010736 | |
| Disease | Nephrotic Syndrome | 1.34e-03 | 27 | 59 | 2 | C0027726 | |
| Disease | osteoporosis (is_implicated_in) | 1.76e-03 | 31 | 59 | 2 | DOID:11476 (is_implicated_in) | |
| Disease | Cholestasis, Extrahepatic | 1.88e-03 | 32 | 59 | 2 | C0005398 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRRRDPGPQSNGPGQ | 26 | A0A494C0Y3 | |
| PGPQSNGPGQEDARA | 31 | A0A494C0Y3 | |
| PGPQSNGPGREDARA | 31 | A0A494C0N9 | |
| GRRRDPGPQSNGPGQ | 26 | P0DSO1 | |
| PGPQSNGPGQEDARA | 31 | P0DSO1 | |
| PRGSSGLQGDPGQTP | 1356 | Q14031 | |
| GPRGQDGARPPGEGS | 296 | Q8TER5 | |
| RGGPRDGPSNLQGSP | 111 | O95076 | |
| RGPPPQSVAGGRRGN | 426 | O94983 | |
| GERGDPGEANTLPGP | 1226 | P08572 | |
| PGPRAPGLQGGSNRD | 41 | Q9NQ90 | |
| GALGGGEEPPRSQAP | 21 | Q9BXU9 | |
| QPGQAPGFPGGADDR | 1031 | Q8WWM7 | |
| AGARGNDGQPGPAGP | 341 | P02458 | |
| PGERGAPGNRGFPGQ | 506 | P02458 | |
| LTQFPRPGGPAQGDG | 791 | Q9Y2K5 | |
| GSGGPGRAEPQLSQP | 46 | O95755 | |
| APGGQGRPEAGRPAS | 1331 | Q86UL8 | |
| NGAPGPKGEGERPAQ | 31 | P52272 | |
| PDQERSRGPGGPQPG | 261 | Q9UPA5 | |
| SRGPGGPQPGSRQAE | 266 | Q9UPA5 | |
| AEAGLPRAGGGSQPP | 26 | Q9UIW2 | |
| DGNSDPNSDGPLGPR | 1106 | Q9HC56 | |
| RGDRGSQGPPGPTGN | 451 | Q5KU26 | |
| PGNELPRGPGESRAG | 46 | Q4G0M1 | |
| GSRPAPEGAGAGPEQ | 46 | Q9ULI4 | |
| AVDPRGGQVPGGPFS | 321 | Q8WWR8 | |
| ERPGAGAASPRAGPQ | 251 | Q9UPP2 | |
| ERAANREGPRGPGGQ | 91 | Q969F2 | |
| PPSQGPGDGERRLSG | 21 | O75400 | |
| RDQPGGPAGRQRPTG | 1416 | O95996 | |
| RDGNPGNDGPPGRDG | 926 | P08123 | |
| NPEPGGRRPEGGLEA | 136 | Q14549 | |
| ENPPRGPGDARAGSG | 636 | Q6ZU35 | |
| PEGNNGRSGDPRPQA | 86 | Q96L14 | |
| PPGSRGNPGSRGENG | 826 | P05997 | |
| GPRGPDGPAGEQGSR | 1066 | Q8IZC6 | |
| EPGPAGSGEPGLRQR | 136 | Q9Y2Y9 | |
| GQEPEGPGATPAGER | 841 | Q76NI1 | |
| SNGAPGQRGEPGPQG | 361 | P02461 | |
| PGADGRPGSPGRAGN | 1301 | Q02388 | |
| AGPPPEKRFDNRGGG | 601 | Q9BUJ2 | |
| PRGTGPSQGPEDNGV | 81 | A6ND36 | |
| NAGGSPSPEPAGRRA | 26 | Q9HA92 | |
| NPPGTPRDDGELGGN | 356 | Q9BWW4 | |
| AEGNPRGGPNQPGQG | 46 | Q8IYN2 | |
| PGTPGAGGRLSPENN | 41 | Q16514 | |
| QGNPGASLDGRPGDR | 16 | O95866 | |
| PPAGRAEPGGGEDRQ | 71 | Q96PQ0 | |
| ARPPSGRAGAPEAQG | 31 | B8ZZ34 | |
| GRAGAPEAQGPAAPG | 36 | B8ZZ34 | |
| QRQGGPPAADAAGPD | 11 | Q14714 | |
| GPAQAPLQGDRGAGP | 41 | Q9NUC0 | |
| GGPRRSPSRGGPDDD | 116 | O75526 | |
| QAGGGGPRPLDQNPG | 186 | P78381 | |
| GRPGAPGPAGARGND | 311 | P02452 | |
| GPEGPQGTVPQGDSR | 396 | A0A0J9YY54 | |
| RARGGGPGEPRGQQP | 96 | Q86Y38 | |
| GPGEPRGQQPASRGA | 101 | Q86Y38 | |
| PADGGRDGAGPRSEP | 76 | Q6ZNH5 | |
| ARGPGGSPQEGTRQP | 881 | Q8IWN7 | |
| GQPGARAAVSGPEGP | 261 | Q96BV0 | |
| GNRGGGDANSDRPPL | 36 | Q9BWH6 | |
| QARVGPADDGPAPSG | 6 | Q9UKN8 | |
| EAGNNSRGPRPGPEG | 231 | O43151 | |
| GDEAQAGRGLPGPDP | 2266 | Q96JG9 | |
| AGRGLPGPDPQSRGA | 2271 | Q96JG9 | |
| GQNGGDAAPARPPAG | 366 | Q8NAF0 | |
| WQERPGAPRGGQGDP | 421 | O15231 | |
| GAPRGGQGDPAVPAQ | 426 | O15231 | |
| PLENRSPGPGSGGER | 211 | Q6P4I2 | |
| PGQPPSAGRARDGGD | 281 | Q86SH2 |